COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 2073: Articles 20721-20730  | Next

Effectiveness of an Ozone Disinfecting and Sanitizing Cabinet to Decontaminate a Surrogate Virus for SARS-CoV-2 on N-95 Masks
Beaudry, M. S., Frederick, J. C., Lott, M. E. J., Norfolk, W. A., Glenn, T. C., Lipp, E. K.
10.1101/2020.11.04.20226233 — Posted: 2020-11-06
Effect of a Mobile-based Intervention on Mental Health in Frontline Healthcare Workers Against COVID-19: Protocol for a Randomized Controlled Trial
Serrano-Ripoll, M. J., Ricci Cabello, I., Jimenez, R., Zamanillo-Campos, R., Yanez Juan, A. M., Bennasar-Veny, M., Sitges, C., Gervilla, E., Leiva, A., Garcia-Campayo, J., Garcia-Buades, E., Garcia-Toro, M., Pastor-Moreno, G., Ruiz-Perez, I., Alonso-Coello, P., Llobera-Canaves, J., Fiol-DeRoque, M. A.
10.1101/2020.11.03.20225102 — Posted: 2020-11-06
Children hospitalized for COVID-19 during first winter of the pandemic in Buenos Aires, Argentina
Raiden, S., Cairoli, H., Potasnik, J., Di Lalla, S., Chiolo, M. J., Torres, F. A., Dominguez, P., Ferrero, F.
10.1101/2020.11.05.20225300 — Posted: 2020-11-06
Nowcasting and forecasting provincial-level SARS-CoV-2 case positivity using google search data in South Africa
Nsoesie, E. O., Sy, K. T. L., Oladeji, O., Sefala, R., Nichols, B. E.
10.1101/2020.11.04.20226092 — Posted: 2020-11-06
Wastewater Analysis of SARS-CoV-2 as a Predictive Metric of Positivity Rate for a Major Metropolis
Stadler, L. B., Ensor, K., Clark, J. R., Kalvapalle, P., LaTurner, Z. W., Mojica, L., Terwilliger, A. L., Zhuo, Y., Ali, P., Avadhanula, V., Bertolusso, R., Crosby, T., Hernandez Santos, H., Hollstein, M., Weesner, K., Zong, D. M., Persse, D., Piedra, P. A., Maresso, A. W., Hopkins, L.
10.1101/2020.11.04.20226191 — Posted: 2020-11-06
Th1 Dominant Nucleocapsid and Spike Antigen-Specific CD4+ and CD8+ Memory T Cell Recall Induced by hAd5 S-Fusion + N-ETSD Infection of Autologous Dendritic Cells from Patients Previously Infected with SARS-CoV-2
Sieling, P., Zakin, L., Shin, A., Morimoto, B., Adisetiyo, H., Garban, H., Liu, P., Rice, A., Taft, J., Patel, R., Buta, S., Martin-Fernandez, M., Bogunovic, D., Gabitzsch, E., Safrit, J. T., Sender, L., Spilman, P., Rabizadeh, S., Niazi, K., Soon-Shiong, P.
10.1101/2020.11.04.20225417 — Posted: 2020-11-06 Discussion: Onsite
Development of an automated chemiluminescence assay system for quantitative measurement of multiple anti-SARS-CoV-2 antibodies
Kubo, S., Ohtake, N., Miyakawa, K., Jeremiah, S. S., Yamaoka, Y., Murohashi, K., Hagiwara, E., Mihara, T., Goto, A., Yamazaki, E., Ogura, T., Kaneko, T., Yamanaka, T., Ryo, A.
10.1101/2020.11.04.20225805 — Posted: 2020-11-06 Discussion: Offsite
Point-of-care detection of SARS-CoV-2 in nasopharyngeal swab samples using an integrated smartphone-based centrifugal microfluidic platform
Soares, R. R. G., Akhtar, A. S., Pinto, I. F., Lapins, N., Barrett, D., Sandh, G., Yin, X., Pelechano, V., Russom, A.
10.1101/2020.11.04.20225888 — Posted: 2020-11-06
Phase 1 trial of a Candidate Recombinant Virus-Like Particle Vaccine for Covid-19 Disease Produced in Plants
Ward, B. J., Gobeil, P., Seguin, A., Atkins, J., Boulay, I., Charbonneau, P.-Y., Couture, M., D'Aoust, M.-A., Dhaliwall, J., Finkle, C., Hager, K., Mahmood, A., Makarkov, A., Cheng, M., Pillet, S., Schimke, P., St-Martin, S., Trepanier, S., Landry, N.
10.1101/2020.11.04.20226282 — Posted: 2020-11-06
Longitudinal proteomic profiling of high-risk patients with COVID-19 reveals markers of severity and predictors of fatal disease
Gisby, J., Clarke, C. L., Medjeral-Thomas, N., Malik, T. H., Papadaki, A., Mortimer, P. M., Buang, N. B., Lewis, S., Pereira, M., Toulza, F., Fagnano, E., Mawhin, M.-A., Dutton, E. E., Tapeng, L., Kirk, P., Behmoaras, J., Sandhu, E., McAdoo, S. P., Prendecki, M. F., Pickering, M. C., Botto, M., Willicombe, M., Thomas, D. C., Peters, J. E.
10.1101/2020.11.05.20223289 — Posted: 2020-11-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).